Legend Biotech Corp (LEGN) Net margin 2018–2025
Legend Biotech Corp (LEGN) net profit margin by fiscal year — reported net income divided by reported revenue.
-28.8%FY2025 · since FY2018: -5.7% → -28.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -28.8% | -0.6 pp |
| FY2024 | -28.2% | +153.6 pp |
| FY2023 | -181.8% | +705.1 pp |
| FY2022 | -886.9% | -300.5 pp |
| FY2021 | -586.4% | -231.2 pp |
| FY2020 | -355.2% | -185.8 pp |
| FY2019 | -169.4% | -163.7 pp |
| FY2018 | -5.7% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More LEGN financial trends
LEGN RevenueLEGN Net incomeLEGN Gross profitLEGN Gross marginLEGN Operating incomeLEGN Operating marginLEGN Operating cash flowLEGN Free cash flowLEGN Capital expendituresLEGN Return on equityLEGN Stock buybacksLEGN Dividends paidLEGN Total assetsLEGN Total liabilitiesLEGN Shareholders’ equityLEGN overview →